A detailed history of Advisory Alpha, LLC transactions in Incyte Corp stock. As of the latest transaction made, Advisory Alpha, LLC holds 7,890 shares of INCY stock, worth $567,527. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,890
Previous 7,240 8.98%
Holding current value
$567,527
Previous $478,000 13.81%
% of portfolio
0.02%
Previous 0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$65.08 - $83.38 $42,302 - $54,197
650 Added 8.98%
7,890 $544,000
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $32,219 - $38,558
562 Added 8.42%
7,240 $478,000
Q2 2024

Aug 21, 2024

BUY
$51.18 - $63.75 $54,353 - $67,702
1,062 Added 18.91%
6,678 $404,000
Q1 2024

May 06, 2024

BUY
$56.55 - $66.59 $317,584 - $373,969
5,616 New
5,616 $319,000
Q1 2020

Apr 29, 2020

SELL
$63.18 - $85.97 $25,272 - $34,388
-400 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $27,901 - $36,565
382 Added 2122.22%
400 $30.8 Million
Q3 2019

Nov 13, 2019

BUY
$72.82 - $86.52 $1,310 - $1,557
18 New
18 $0
Q2 2019

Aug 16, 2019

SELL
$73.52 - $88.7 $1,102 - $1,330
-15 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$63.56 - $88.17 $953 - $1,322
15 New
15 $0

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.